Skip to content

Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates.

Márcia Carvalho, Nuno Milhazes, Fernando Remião, Fernanda Borges, Eduarda Fernandes, Francisco Amado, Terrence J. Monks, Félix Carvalho, Maria Lourdes Bastos

Archives of Toxicology January 2004 DOI: 10.1007/s00204-003-0510-7 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics In vitro laboratory study Peer reviewed
Population Freshly isolated rat hepatocyte suspensions
Interventions MDA alpha-methyldopamine (alpha-MeDA)
Dose 0.1, 0.2, 0.4, 0.8, or 1.6 mM
Duration 3 h incubation
Measures cell viability, lipid peroxidation, glutathione (GSH), glutathione disulfide (GSSG), GSH conjugates, GSSG reductase (GR), GSH peroxidase (GPX), GSH S-transferase (GST)
Key points MDA and its metabolite alpha-MeDA depleted glutathione in rat hepatocytes; alpha-MeDA at 1.6 mM also reduced cell viability and glutathione-related enzyme activities, while neither compound significantly increased lipid peroxidation. Glutathione depletion occurred without oxidized glutathione accumulation, and glutathione conjugates of alpha-MeDA were detected, which the authors propose indicates that MDMA metabolism disrupts thiol homeostasis and may initiate cellular damage.

Abstract

The amphetamine designer drugs 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and its N-demethylated analogue 3,4-methylenedioxyamphetamine (MDA or "love") have been extensively used as recreational drugs of abuse. MDA itself is a main MDMA metabolite. MDMA abuse in humans has been associated with numerous reports of hepatocellular damage. Although MDMA undergoes extensive hepatic metabolism, the role of metabolites in MDMA-induced hepatotoxicity remains unclear. Thus, the aim of the present study was to evaluate the effects of MDA and alpha-methyldopamine (alpha-MeDA), a major metabolite of MDA, in freshly isolated rat hepatocyte suspensions. The cells were incubated with MDA or alpha-MeDA at final concentrations of 0.1, 0.2, 0.4, 0.8, or 1.6 mM for 3 h. The toxic effects induced following incubation of hepatocyte suspensions with these metabolites were evaluated by measuring cell viability, the extent of lipid peroxidation, levels of glutathione (GSH) and glutathione disulfide (GSSG), the formation of GSH conjugates, and the activities of GSSG reductase (GR), GSH peroxidase (GPX), and GSH S-transferase (GST). MDA induced a concentration- and time-dependent GSH depletion, but had a negligible effect on lipid peroxidation, cell viability, or on the activities of GR, GPX, and GST. In contrast, alpha-MeDA (1.6 mM, 3 h) induced a marked depletion of GSH accompanied by a loss on cell viability, and decreases in GR, GPX and GST activities, although no significant effect on lipid peroxidation was found. For both metabolites, GSH depletion was not accompanied by increases in GSSG levels; rather, 2-(glutathion- S-yl)-alpha-MeDA and 5-(glutathion- S-yl)-alpha-MeDA were identified by HPLC-DAD/EC within cells incubated with MDA or alpha-MeDA. The results provide evidence that one of the early consequences of MDMA metabolism is a disruption of thiol homeostasis, which may result in loss of protein function and the initiation of a cascade of events leading to cellular damage.

Citations in the library

Cited by 20

and 15 more in the library

Cites 14

and 9 more in the library

Explore topics